Advanced search
Publication Cover
Journal of Medical Economics Volume 12, 2009 - Issue 1
Submit an article Journal homepage
347
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Antidepressant treatment patterns and costs among US employees

Howard Birnbaum Analysis Group, Inc., Boston, MA, USA
,
Paul E. Greenberg Analysis Group, Inc., Boston, MA, USA
,
Jackson Tang Analysis Group, Inc., Boston, MA, USA
,
Matthew Hsieh Analysis Group, Inc., Boston, MA, USA
,
Eric Q. Wu Analysis Group, Inc., Boston, MA, USA
,
Caroline Amand sanofi-aventis Research and Development, Paris, France
&
Rym Ben-Hamadi Analysis Group, Inc., Boston, MA, USA
 show all
Pages 36-45 | Accepted 19 Jan 2009, Published online: 30 Apr 2009

References

  • Greenberg PE, Kessler RC, Birnbaum HG, et al. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry 2003;64(12):1465–1475.
  • Kessler RC, Berglund P, Demler O, et al. National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289(23):3095–3105.
  • Bloom BS. Prevalence and economic effects of depression. Manag Care 2004;13(6 Suppl):9–16.
  • Greenberg PE, Stiglin LE, Finkelstein SN, Berndt ER. The economic burden of depression in 1990. J Clin Psychiatry 1993;54(11):405–418.
  • Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997;349(9064):1498-1504.
  • Kessler RC, Akiskal HS, Ames M, et al. Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers. Am J Psychiatry 2006;163(9):1561–1568.
  • Crown WH, Finkelstein S, Berndt ER, et al. The impact of treatment-resistant depression on health care utilization and costs. J Clin Psychiatry 2002;63:963–971.
  • Corey-Lisle PK, Birnbaum H, Greenberg PEP, et al. Identification of a claims data “signature” and economic consequences for treatment-resistant depression. J Clin Psychiatry 2002;63(8):717–726.
  • Russell JM, Hawkins K, Ozminkowski RJ, et al. The cost consequences of treatment-resistant depression. J Clin Psychiatry 2004;65(3):341–347.
  • Greenberg PE, Corey-Lisle PK, Birnbaum H, et al. Economic implications of treatment-resistant depression among employees. Pharmacoeconomics 2004;22(6):363–373.
  • Thompson D, Buesching D, Gregor KJ, Oster G. Patterns of antidepressant use and their relation to costs of care. Am J Manage Care 1996;2:1239–1246.
  • Simon GE. Evidence review: efficacy and effectiveness of antidepressant treatment in primary care. Gen Hosp Psychiatry 2002;24(4):213–224.
  • Melfi CA, Chawla AJ, Croghan TW, et al. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Arch Gen Psychiatry 1998;55(12):1128–1132.
  • Melartin TK, Rytsala HJ, Leskela US, et al. Continuity is the main challenge in treating major depressive disorder in psychiatric care. J Clin Psychiatry 2005;66(2):220–227.
  • Antidepressant Medication Management. The state of health care quality, National Committee for quality assurance. Washington, DC: 2006;1.
  • Akincigil A, Bowblis JR, Levin C, et al. Adherence to antidepressant treatment among privately insured patients diagnosed with depression. Med Care 2007;45(4):363–369.
  • Burton WN, Chen CY, Conti DJ, et al. The association of antidepressant medication adherence with employee disability absences. Am J Manag Care 2007;13(2):105–112.
  • Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613–619.
  • Duan N, Manning WG, Morris CN, Newhouse JP. A comparison of alternative models for the demand for medical care. J Bus Econ Stat 1983;1(2):115–126.
  • Wedderburn RWM. Quasi-likelihood functions, generalized linear models, and the Gauss-Newton method. Biometrika 1974;61:439–447.
  • Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ 2001;20:461–494.
  • Manning WG. The logged dependent variable, heteroscedasticity, and the retransformation problem. J Health Econ 1998; 17:283–295.
  • Trivedi MH, Rush AJ, Wisniewski SR, et al. and STAR*D Study Team. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006;163:28–40.
  • Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D Report. Am J Psychiatry 2006;163(11):1905–17.
  • Birnbaum H, Ben-Hamadi R, Greenberg P, et al. Determinants of direct cost differences among U.S employees with major depressive disorders using antidepressants. Pharmacoeconomics, forthcoming

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.